These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1978468)

  • 21. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.
    Kane JM; Carson WH; Saha AR; McQuade RD; Ingenito GG; Zimbroff DL; Ali MW
    J Clin Psychiatry; 2002 Sep; 63(9):763-71. PubMed ID: 12363115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia--a Canadian multicentre trial.
    Lapierre YD; Nair NP; Chouinard G; Awad AG; Saxena B; Jones B; McClure DJ; Bakish D; Max P; Manchanda R
    Acta Psychiatr Scand Suppl; 1990; 358():72-7. PubMed ID: 1978496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
    Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME
    Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An open multicentre study of the treatment of florid schizophrenia with remoxipride.
    McCreadie RG; Morrison D; Eccleston D; Gall RG; Loudon J; Mitchell MJ
    Acta Psychiatr Scand; 1985 Aug; 72(2):139-43. PubMed ID: 2864790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation.
    Chouinard G
    Acta Psychiatr Scand Suppl; 1990; 358():111-9. PubMed ID: 1978469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EEG-brain mapping in schizophrenics with predominantly positive and negative symptoms. Comparative studies with remoxipride/haloperidol.
    Saletu B; Küfferle B; Anderer P; Grünberger J; Steinberger K
    Eur Neuropsychopharmacol; 1990 Nov; 1(1):27-36. PubMed ID: 1983779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dose-finding study with remoxipride in the acute treatment of schizophrenic patients.
    Lapierre YD; Ancill R; Awad G; Bakish D; Beaudry P; Bloom D; Chandrasena R; Das M; Durand C; Elliott D
    J Psychiatry Neurosci; 1992 Oct; 17(4):134-45. PubMed ID: 1450186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
    Cesková E; Svestka J
    Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.
    Arvanitis LA; Miller BG
    Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The treatment of negative symptoms: a clinical and methodological study.
    Lapierre YD; Angus C; Awad AG; Saxena BM; Jones B; Williamson P; Vincent P; Carle R; Lavallee YJ; Manchanda R; Gauthier B; Wolf MA; Teehan MD; Denis JF; Malla AK; Oyewumi LK; Busse E; Labelle A; Claesson L; Grafford K
    Int Clin Psychopharmacol; 1999 Mar; 14(2):101-12. PubMed ID: 10220125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma concentration of remoxipride in relation to antipsychotic effect and adverse symptoms. The Canadian Remoxipride Study Group.
    Jostell KG; Lapierre YD
    Acta Psychiatr Scand Suppl; 1990; 358():48-50. PubMed ID: 1978488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder.
    Goff DC; Posever T; Herz L; Simmons J; Kletti N; Lapierre K; Wilner KD; Law CG; Ko GN
    J Clin Psychopharmacol; 1998 Aug; 18(4):296-304. PubMed ID: 9690695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A placebo controlled trial of remoxipride in the prevention of relapse in chronic schizophrenia.
    King DJ; Blomqvist M; Cooper SJ; Doherty MM; Mitchell MJ; Montgomery RC
    Psychopharmacology (Berl); 1992; 107(2-3):175-9. PubMed ID: 1352050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olanzapine versus haloperidol treatment in first-episode psychosis.
    Sanger TM; Lieberman JA; Tohen M; Grundy S; Beasley C; Tollefson GD
    Am J Psychiatry; 1999 Jan; 156(1):79-87. PubMed ID: 9892301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tolerability and efficacy of the atypical neuroleptic remoxipride compared with clozapine and haloperidol in acute schizophrenia.
    Klieser E; Strauss WH; Lemmer W
    Acta Psychiatr Scand Suppl; 1994; 380():68-73. PubMed ID: 8048341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
    Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
    Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies.
    Janicak PG; Glick ID; Marder SR; Crandall DT; McQuade RD; Marcus RN; Eudicone JM; Assunção-Talbott S
    J Clin Psychiatry; 2009 Jan; 70(1):25-35. PubMed ID: 19192472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
    Keefe RS; Seidman LJ; Christensen BK; Hamer RM; Sharma T; Sitskoorn MM; Lewine RR; Yurgelun-Todd DA; Gur RC; Tohen M; Tollefson GD; Sanger TM; Lieberman JA
    Am J Psychiatry; 2004 Jun; 161(6):985-95. PubMed ID: 15169686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life and response of negative symptoms in schizophrenia to haloperidol and the atypical antipsychotic remoxipride. The Canadian Remoxipride Group.
    Awad AG; Lapierre YD; Angus C; Rylander A
    J Psychiatry Neurosci; 1997 Jul; 22(4):244-8. PubMed ID: 9262046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.
    Crespo-Facorro B; Pérez-Iglesias R; Ramirez-Bonilla M; Martínez-García O; Llorca J; Luis Vázquez-Barquero J
    J Clin Psychiatry; 2006 Oct; 67(10):1511-21. PubMed ID: 17107241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.